Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Advisors
Partners
Careers
Technology
NETs Platform
SubB2M Platform
hTERT ICC Assay
Intellectual Property
Publications & Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
EXO-OC™ Ovarian Cancer Screening Test
Exosome Therapeutics
NeuCA15-3 Test
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
INOVIQ in the News
Heading &
Sub-heading can be edited through HQI
News & Events
>
INOVIQ in the News
INOVIQ in the News
Conferences & Events
INOVIQ in the News
Filter by Year:
2026
2025
2024
2023
2022
2021
2020
2018
Older
21-Dec-2021
Bard1 Awarded Biomedical Translation Bridge Funding to Develop Breast Cancer Tests
4-Nov-2021
BARD1 Life Sciences (ASX:BD1) Presentation, FNN Online Investor Event, October 2021
15-Feb-2021
INOVIQ reveals its SubB2M technology can detect all stages of breast cancer from a blood sample, 100% specificity and 95% sensitivity.
14-Feb-2021
INOVIQ share price doubles following positive announcement on ovarian cancer detection technology.
1
